IPG Photonics Valuation
Is 0J86 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0J86 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0J86 ($76.99) is trading below our estimate of fair value ($87.68)
Significantly Below Fair Value: 0J86 is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0J86?
Key metric: As 0J86 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 0J86's PS Ratio? | |
|---|---|
| PS Ratio | 3.2x |
| Sales | US$1.04b |
| Market Cap | US$3.36b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.3x |
| Enterprise Value/EBITDA | 25.3x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 0J86's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.1x | ||
GHH Gooch & Housego | 0.8x | 2.7% | UK£118.2m |
SXS Spectris | 1.9x | 5.8% | UK£2.5b |
RSW Renishaw | 3.3x | 5.3% | UK£2.3b |
OXIG Oxford Instruments | 2.5x | 4.4% | UK£1.2b |
0J86 IPG Photonics | 3.2x | 7.4% | US$3.4b |
Price-To-Sales vs Peers: 0J86 is expensive based on its Price-To-Sales Ratio (3.2x) compared to the peer average (2.1x).
Price to Sales Ratio vs Industry
How does 0J86's PS Ratio compare vs other companies in the GB Electronic Industry?
Price-To-Sales vs Industry: 0J86 is expensive based on its Price-To-Sales Ratio (3.2x) compared to the UK Electronic industry average (1.4x).
Price to Sales Ratio vs Fair Ratio
What is 0J86's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 3.2x |
| Fair PS Ratio | 2.2x |
Price-To-Sales vs Fair Ratio: 0J86 is expensive based on its Price-To-Sales Ratio (3.2x) compared to the estimated Fair Price-To-Sales Ratio (2.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$76.99 | US$86.17 +11.9% | 19.8% | US$100.00 | US$50.00 | n/a | 6 |
| Nov ’25 | US$82.73 | US$86.17 +4.2% | 19.8% | US$100.00 | US$50.00 | n/a | 6 |
| Oct ’25 | US$71.94 | US$84.67 +17.7% | 20.1% | US$100.00 | US$50.00 | n/a | 6 |
| Sep ’25 | US$68.71 | US$87.17 +26.9% | 20.6% | US$100.00 | US$50.00 | n/a | 6 |
| Aug ’25 | US$76.42 | US$87.17 +14.1% | 20.6% | US$100.00 | US$50.00 | n/a | 6 |
| Jul ’25 | US$83.95 | US$100.88 +20.2% | 17.2% | US$127.00 | US$68.00 | n/a | 8 |
| Jun ’25 | US$85.92 | US$103.86 +20.9% | 20.2% | US$130.00 | US$68.00 | n/a | 7 |
| May ’25 | US$83.03 | US$105.74 +27.4% | 17.5% | US$130.00 | US$74.00 | n/a | 8 |
| Apr ’25 | US$91.25 | US$110.59 +21.2% | 17.7% | US$130.70 | US$74.00 | n/a | 8 |
| Mar ’25 | US$88.00 | US$110.59 +25.7% | 17.7% | US$130.70 | US$74.00 | n/a | 8 |
| Feb ’25 | US$98.52 | US$124.34 +26.2% | 17.2% | US$170.00 | US$91.00 | n/a | 8 |
| Jan ’25 | US$108.90 | US$122.10 +12.1% | 19.5% | US$170.00 | US$86.00 | n/a | 7 |
| Dec ’24 | US$97.29 | US$120.67 +24.0% | 21.1% | US$170.00 | US$86.00 | n/a | 6 |
| Nov ’24 | US$85.17 | US$121.57 +42.7% | 19.5% | US$170.00 | US$86.00 | US$82.73 | 7 |
| Oct ’24 | US$101.24 | US$131.57 +30.0% | 15.0% | US$170.00 | US$107.00 | US$71.94 | 7 |
| Sep ’24 | US$108.54 | US$131.57 +21.2% | 15.0% | US$170.00 | US$107.00 | US$68.71 | 7 |
| Aug ’24 | US$108.68 | US$138.14 +27.1% | 12.8% | US$170.00 | US$112.00 | US$76.42 | 7 |
| Jul ’24 | US$135.12 | US$138.14 +2.2% | 12.8% | US$170.00 | US$112.00 | US$83.95 | 7 |
| Jun ’24 | US$114.09 | US$132.83 +16.4% | 9.8% | US$152.00 | US$112.00 | US$85.92 | 6 |
| May ’24 | US$109.92 | US$131.50 +19.6% | 14.2% | US$160.00 | US$105.00 | US$83.03 | 6 |
| Apr ’24 | US$114.63 | US$131.50 +14.7% | 14.2% | US$160.00 | US$105.00 | US$91.25 | 6 |
| Mar ’24 | US$125.57 | US$127.14 +1.3% | 16.0% | US$160.00 | US$101.00 | US$88.00 | 7 |
| Feb ’24 | US$113.22 | US$109.43 -3.4% | 10.1% | US$130.00 | US$95.00 | US$98.52 | 7 |
| Jan ’24 | n/a | US$109.00 0% | 11.8% | US$130.00 | US$85.00 | US$108.90 | 8 |
| Dec ’23 | US$90.35 | US$109.00 +20.6% | 11.8% | US$130.00 | US$85.00 | US$97.29 | 8 |
| Nov ’23 | US$86.96 | US$125.00 +43.7% | 18.8% | US$165.00 | US$85.00 | US$85.17 | 7 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Midwich Group
UK£285.5m
Distributes audio visual (AV) solutions to trade customers in the United Kingdom, Ireland, rest of Europe, the Middle East, Africa, the Asia Pacific, and North America.
MIDW
UK£2.79
7D
-3.8%
1Y
-24.2%
Cicor Technologies
CHF 183.5m
Develops and manufactures electronic components, devices, and systems worldwide.
0QPR
CHF 57.20
7D
0.4%
1Y
29.7%
Datalogic
€273.6m
Manufactures and sells automatic data capture and process automation products worldwide.
0E3C
€5.14
7D
-1.4%
1Y
-11.9%